StockNews.com initiated coverage on shares of Bellerophon Therapeutics (NASDAQ:BLPH – Free Report) in a research note released on Monday. The brokerage issued a hold rating on the biotechnology company’s stock.
Bellerophon Therapeutics Price Performance
BLPH opened at $0.05 on Monday. Bellerophon Therapeutics has a fifty-two week low of $0.03 and a fifty-two week high of $11.15. The firm has a market capitalization of $624,953.00, a price-to-earnings ratio of -0.06 and a beta of 0.67. The company’s 50 day moving average price is $0.05 and its two-hundred day moving average price is $0.06.
Bellerophon Therapeutics Company Profile
Read More
- Five stocks we like better than Bellerophon Therapeutics
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- It’s Time to Buy Into the Super Micro Computer Stock Implosion
- Consumer Discretionary Stocks Explained
- Merger or Not, Albertson’s Companies is a Good Buy
- How Can Investors Benefit From After-Hours Trading
- 3 Cheap Stocks That Shouldn’t Be So
Receive News & Ratings for Bellerophon Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bellerophon Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
